STAT

JULY 24, 2023

The House Ways & Means Committee package includes a new provision that would ensure that patients in the Medicare program pay for medicines they pick up at the pharmacy counter based on the discounted price that insurers negotiate with drugmakers, instead of higher sticker prices, starting in 2027.

Packaging 232

Packaging Drug Pricing Hospitals 232

STAT

DECEMBER 7, 2023

One expires next year and the other in 2027, well beyond the original patent expiration date. The move meant that the company, which is now part of Bristol Myers Squibb, won several more years of valuable patent protection than it would have received had it applied for the extra patents when submitting its data to the FDA.

Drug Pricing 282

Drug Pricing Compounding Pharmaceutical Companies Pharmaceutical Companies 282

STAT

JANUARY 17, 2023

The number of health care-related artificial intelligence models on the market has increased steadily over the past decade, with the health care AI market expected to grow from $7 billion today to $67 billion in 2027.

221

221

BioPharma Dive

NOVEMBER 15, 2023

The deal gives Gilead an estimated 13% ownership in Arcellx and extends the company’s cash runway into 2027.

112

112

Outsourcing Pharma

OCTOBER 24, 2023

Traditionally, the pharmaceutical landscape has been dominated by small molecules.

64

64

PharmaTech

OCTOBER 26, 2023

As CMOs continue to invest in cell culture capacity, some are expected to surpass top in-house companies.

52

52

Pharmaceutical Commerce

APRIL 5, 2023

Rise in value attributed to the ongoing decentralization of pharmacies.

52

52

PharmExec

FEBRUARY 9, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

40

40

STAT

NOVEMBER 20, 2023

Under the new agreement, the level of allowed growth in drug sales will increase from 2% in 2024 to 4% by 2027. The current plan, which has drawn the ire of pharma companies, requires drug companies to pay rebates back to the U.K. if spending on medicines increases by more than 2% a year. Continue to STAT+ to read the full story…

215

215

Pharmaceutical Technology

OCTOBER 6, 2023

Biologics are poised to overtake innovative small molecules in terms of sales revenue by 2027, with forecast sales of $120bn.

59

59

Express Pharma

DECEMBER 13, 2023

Commercialisation is targeted for 2027 Asahi Kasei has developed a novel membrane system for dehydrating organic solvents for pharma applications without the application of heat or pressure. This system can contribute to the optimisation of manufacturing processes in the pharma industry.

Pharmaceutical Manufacturing 91

Pharmaceutical Manufacturing 91

Pharmacy Times

JANUARY 10, 2023

The report highlights the growth of personalized medicines with improved efficacy for rare, previously untreatable diseases.

52

52

The Guardian - Pharmaceutical Industry

SEPTEMBER 21, 2023

The commission’s investigation was made public last week by the health department and the Health Justice Initiative (HJI) legal organisation at a media briefing of Médecins Sans Frontières (MSF).

Drug Pricing 82

Drug Pricing 82

Pharmaceutical Commerce

JANUARY 25, 2023

Annual report finds continuing impact of COVID-19 on global markets

52

52

Pharmafile

JANUARY 25, 2023

The facility is expected to become operational in 2027 and will create over 100 new jobs for manufacturing personnel. Lilly’s expansion is set to include the addition of further parenteral filling, device assembly and packaging capacity in order to meet the growing demand for the company’s incretin-based diabetes treatments and medications.

Packaging 52

Packaging Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

MARCH 15, 2023

The committee has also launched new targets for December 2027. Additionally, 50 of the private companies in the UK need to have a minimum of one ethnic minority director on the main board by December 2027. Under these targets, each FTSE 350 company will be required to set a percentage target for senior management positions.

52

52

European Pharmaceutical Review

FEBRUARY 27, 2024

The facility has been designed to meet the highest environmental sustainability standards, to help Amgen’s reach its target of carbon neutrality in all operations by 2027, the company noted. .” Amgen Ohio is nearly 300,000 ft 2 in size and will employ 400 full-time staff.

Biosimilars 98

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 98

pharmaphorum

JANUARY 4, 2022

An appeals court ruling has upheld the validity of a key US patent covering Gilenya (fingolimod), and issued a permanent injunction against HEC Pharma until it expires in December 2027. Generics could still appear on the US market before the end of 2027 however.

59

59

Big Molecule Watch

NOVEMBER 6, 2023

In that case, according to CMS’s guidance, STELARA would cease to be “selected” on January 1, 2027. FDA’s approval of WEZLANA has also been raised as a pertinent fact in one of the pending challenges to the Drug Price Negotiation Program.

Drug Pricing 67

Drug Pricing Biosimilars 67

Pharma Mirror

JANUARY 26, 2023

billion by 2027. At the same time, Asia-Pacific pharma players expect their businesses to grow rapidly in the upcoming year. With an estimated CAGR of 10.5%, the APAC market is expected to reach a booming $64.96 Simultaneously, China remains the world’s biggest pharma producer, with an estimated value of around $573.5 billion in 2022.

Vaccines 52

Vaccines 52

European Pharmaceutical Review

MARCH 14, 2024

A global Phase III clinical trial is being planned, with an expected regulatory submission in 2027. The data from the studies suggested that the vaccine has “blockbuster potential”, according to SK bioscience.

Vaccines 81

Vaccines 81

Express Pharma

DECEMBER 21, 2023

The board of directors at its meeting held on December 19, 2023, approved the execution of a trade mark licence agreement with Novartis Innovative Therapies AG, which is perpetual in nature for the Indian market, for a portfolio of select ophthalmology brands which will be effective in January 2027, JB Pharma said in a regulatory filing.

97

97

Big Molecule Watch

MARCH 1, 2024

The opposition states, “Biocon already has the certainty it requires for years to come—it is an adjudged infringer of a patent that does not expire until June 2027 and will not be able to commercialize its product until at least that time. The ’865 patent does not expire until June 2027. The post Post-Trial Updates on Regeneron v.

Biosimilars 67

Biosimilars 67

RX Note

OCTOBER 12, 2023

The European Union has enacted a law that mandates smartphone manufacturers to design devices with replaceable batteries by 2027. What often compel users to upgrade a new phone is not due to slowing processing speed or exciting features, but because of a failing battery. External Links iPhone battery and performance EU does it again!

40

40

European Pharmaceutical Review

OCTOBER 16, 2023

The new filling line is projected to be operational in 2027. Approximately 115 new jobs are expected to be created. Enhancing manufacturing capabilities The bioconjugates market is currently valued at $33 billion according to research by Lonza.

Compounding 92

Compounding 92

European Pharmaceutical Review

NOVEMBER 20, 2023

While the new site is anticipated to be operational at the start of 2027, the investment in Alzey is contingent upon finalisation of government permitting and local approvals, Eli Lilly stated. To support reliable medicine supply, since 2020, Eli Lilly has announced investments of over $11 billion in its global manufacturing footprint.

Diabetes 81

Diabetes 81

Pharma Mirror

APRIL 16, 2021

With increasing proclivity towards these pharmacies, the compounding pharmacies market is estimated to witness commendable growth over the coming years by registering a significant valuation of USD 15 billion by 2027. Recently, worldwide outbreak of COVID-19 has disrupted the supply chains delaying the delivery of raw materials which.

Compounding Pharmacies 52

Compounding Pharmacies Compounding Community Pharmacies 52

European Pharmaceutical Review

OCTOBER 18, 2022

Global pharma contract manufacturing market to value $120bn by 2027… The post HPAPI contract manufacturing to value $14.6 billion by 2030 appeared first on European Pharmaceutical Review.

Dosage 91

Dosage Vaccines 91

PharmaShots

APRIL 6, 2023

Under the BsuFA III program, in 2022, the US FDA has granted $5M new research funding for 5 research proposals ($1M per award per year) under the regulatory science pilot program BsUFA III (FY 2023-2027) was implemented on Oct 1st, 2022, followed by BsUFA I (FY 2023-2027) and BsUFA II (FY 2018– 2022) with the aim (demonstration projects): 1) (..)

Biosimilars 53

Biosimilars Clinical Pharmacology 53

Pharmaceutical Technology

MAY 19, 2023

AbbVie anticipates Rinvoq sales to exceed $7.5bn in 2025 and for the peak revenues from both drugs to exceed Humira’s peak sales by 2027.

Mayo Clinic 105

Mayo Clinic Dosage Biosimilars Immunity 105

Pharmaceutical Business Review

DECEMBER 4, 2023

” The deal is expected to be accretive to diluted earnings per share beginning in 2027. This transaction is the culmination of our 40-year commitment to develop and deliver the next-generation of ADCs and more good days for people living with cancer.”

Labelling 59

Labelling 59

European Pharmaceutical Review

DECEMBER 2, 2022

The facility is planned for completion in 2027. The investment will support the addition of new technologies to ensure Pfizer is ready to facilitate the next generation of medical innovations, and to help increase capacity for licensed and pipeline products in oncology, rare disease, inflammation & immunology and internal medicines.

Vaccines 91

Vaccines 91

European Pharmaceutical Review

SEPTEMBER 21, 2023

The Novo Nordisk Foundation Cellerator is expected to be in operation in 2027. “We believe the Novo Nordisk Foundation Cellerator can be a leading player in Europe and a model for similar facilities around the world,” Professor Mads Krogsgaard Thomsen, CEO of the Novo Nordisk Foundation commented.

Hospitals 106

Hospitals 106

Digital Pharmacist

MARCH 19, 2024

According to the Centers for Medicare and Medicaid Services (CMS), healthcare costs are on the rise and predicted to increase nearly 50% by 2027. Millennials make up more than 35% of the country’s workforce , while older Gen Zers (born 1997-2012) are already graduating college and starting their first professional jobs.

104

104

European Pharmaceutical Review

FEBRUARY 8, 2023

Breyanzi sales will also be supplemented by the anticipated approval in chronic lymphocytic leukemia (CLL) in 2027, making it the first and only currently marketed CD19 CAR-T agent to penetrate the CLL market. Breyanzi will exhibit the largest compound annual growth rate (CAGR) at 30 percent, compared to Yescarta’s CAGR of 9 percent.

Labelling 93

Labelling Compounding 93

European Pharmaceutical Review

JULY 18, 2022

Nebido is also patented until March 2024 in the European Union and until May 2027 in the United States. The long-acting injectable treatment for testosterone deficiency has been commercially approved in more than 80 countries.

79

79

pharmaphorum

NOVEMBER 25, 2020

Jefferies expects that the company expects sales of $14 billion could be at risk by 2027 from patent expiries of Tasigna, Promacta, Jakavi, Gilenya and Entresto. In the short term, the analysts predict “flattish” Q4 sales, although they noted that the company may benefit from cost savings introduced during the COVID-19 pandemic.

Biosimilars 119

Biosimilars Hospitals 119